These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25657416)

  • 1. Severe cutaneous adverse drug reactions: a clinicoepidemiological study.
    Sasidharanpillai S; Riyaz N; Khader A; Rajan U; Binitha MP; Sureshan DN
    Indian J Dermatol; 2015; 60(1):102. PubMed ID: 25657416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
    Singh GK; Mitra B; Arora S; Akhoon N; Verma R; Sharma P; Mitra D
    Int J Dermatol; 2021 May; 60(5):579-588. PubMed ID: 33454956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
    Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
    Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital.
    Lekshmipriya K; Pradeesh A; Vasudevan B; Dash M; Sood A; Gera V
    Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S209-S216. PubMed ID: 38144617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug reaction with eosinophilia and systemic symptoms].
    Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
    Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
    Mustafa SS; Ostrov D; Yerly D
    Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia.
    AlJasser MI
    Dermatol Res Pract; 2023; 2023():8928198. PubMed ID: 37206671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia.
    Loo CH; Tan WC; Khor YH; Chan LC
    Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
    Barbaud A; Collet E; Milpied B; Assier H; Staumont D; Avenel-Audran M; Grange A; Amarger S; Girardin P; Guinnepain MT; Truchetet F; Lasek A; Waton J;
    Br J Dermatol; 2013 Mar; 168(3):555-62. PubMed ID: 23136927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in China.
    Deng M; Su Y; Wu R; Li S; Tang G; Kuang Q; Luo X; Zhu Y; Shen W
    Int Immunopharmacol; 2023 Jan; 114():109530. PubMed ID: 36508915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
    Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
    J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
    Latha S; Choon SE
    Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P; Aw CW
    Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopic Aspects of Cutaneous Adverse Drug Reactions.
    Rossi G; da Silva Cartell A; Marchiori Bakos R
    Dermatol Pract Concept; 2021 Jan; 11(1):e2021136. PubMed ID: 33614215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Allergol Select; 2017; 1(1):96-108. PubMed ID: 30402608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe cutaneous adverse reactions in a tertiary care center in Jamaica.
    McNish AJS; Ho JD; East-Innis ADC
    JAAD Int; 2024 Jun; 15():139-146. PubMed ID: 38545494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Drug Hypersensitivity Reactions: Clinical Pattern, Diagnosis, Etiology and Therapeutic Options.
    Paulmann M; Mockenhaupt M
    Curr Pharm Des; 2016; 22(45):6852-6861. PubMed ID: 27779083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological study of cutaneous adverse drug reactions in oman.
    Al-Raaie F; Banodkar DD
    Oman Med J; 2008 Jan; 23(1):21-7. PubMed ID: 22567204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.